Metoperan 2.6 Uses

Was this medicine useful for you?
sponsored

What is Metoperan 2.6?

Metoperan 2.6 is used to treat the symptoms of a certain type of stomach problem called gastroparesis in patients with diabetes. It works by increasing the movements or contractions of the stomach and intestines. It relieves symptoms such as nausea, vomiting, heartburn, a feeling of fullness after meals, and loss of appetite. Metoperan 2.6 is also used to treat heartburn for patients with gastroesophageal reflux disease (GERD). GERD is esophageal irritation from the backward flow of gastric acid into the esophagus.

Metoperan 2.6 is available only with your doctor's prescription.

Once a medicine has been approved for marketing for a certain use, experience may show that it is also useful for other medical problems. Although these uses are not included in product labeling, Metoperan 2.6 is used in certain patients with the following medical conditions:

Metoperan 2.6 indications

sponsored

Metoperan 2.6 increases muscle contractions in the upper digestive tract. This speeds up the rate at which the stomach empties into the intestines.

Metoperan 2.6 is used short-term to treat heartburn caused by gastroesophageal reflux in people who have used other medications without relief of symptoms.

Metoperan 2.6 is also used to treat slow gastric emptying in people with diabetes (also called diabetic gastroparesis), which can cause nausea, vomiting, heartburn, loss of appetite, and a feeling of fullness after meals.

How should I use Metoperan 2.6?

Use Metoperan 2.6 as directed by your doctor. Check the label on the medicine for exact dosing instructions.

Ask your health care provider any questions you may have about how to use Metoperan 2.6.

Uses of Metoperan 2.6 in details

sponsored

How to use Metoperan 2.6 injection

Metoperan 2.6 description

Each ampoule of injection contains anhydrous Metoperan 2.6 (as Metoperan 2.6) 10 mg in 2 mL and sodium chloride in water for injections. When necessary, pH is adjusted with sodium hydroxide and/or hydrochloric acid.

Metoperan 2.6 is 4-amino-5-chloro-N-(2-diethylaminoethyl)-2-methoxybenzamide HCl monohydrate. It has a molecular weight of 354.3 and its molecular formula is C14H22ClN3O2·HCl·H2O.

Metoperan 2.6 hydrochloride occurs as a white or almost white, crystalline powder or crystals, very soluble in water, freely soluble in alcohol, sparingly soluble in methylene chloride, practically insoluble in ether.

Metoperan 2.6 dosage

Usual Adult Metoperan 2.6 Dose for Nausea/Vomiting:

Postoperative nausea and vomiting:

Parenteral: 10 to 20 mg IM at or near the end of surgery

Usual Adult Metoperan 2.6 Dose for Gastroesophageal Reflux Disease:

Oral: 10 to 15 mg up to 4 times a day 30 minutes before meals and at bedtime, depending upon symptoms being treated and clinical response. Therapy should not exceed 12 weeks.

Usual Adult Metoperan 2.6 Dose for Small Intestine Intubation:

If the tube has not passed the pylorus with conventional methods in 10 minutes, a single (undiluted) dose may be administered IV slowly over 1 to 2 minutes:

Adults and pediatric patients greater than or equal to 14 years: 10 mg IV as a single dose administered over 1 to 2 minutes.

Usual Adult Metoperan 2.6 Dose for Radiographic Exam:

Adults and pediatric patients greater than or equal to 14 years: 10 mg IV as a single dose administered over 1 to 2 minutes to facilitate gastric emptying where delayed gastric emptying interferes with radiological examination of the stomach and/or small intestine.

Usual Adult Metoperan 2.6 Dose for Gastroparesis:

During the earliest manifestations of diabetic gastric stasis, oral administration may be initiated. If severe symptoms are present, therapy should begin with IM or IV administration for up to 10 days until symptoms subside at which time the patient can be switched to oral therapy. Since diabetic gastric stasis is often recurrent, therapy should be reinstituted at the earliest manifestation.

Parenteral: 10 mg 4 times daily, IV (slowly over a 1 to 2 minute period) or IM for up to 10 days.

Oral: 10 mg 4 times daily, 30 minutes before meals and at bedtime, for 2 to 8 weeks depending on clinical response.

Usual Adult Metoperan 2.6 Dose for Nausea/Vomiting -- Chemotherapy Induced:

IV infusion: 1 to 2 mg/kg/dose (depending on the emetogenic potential of the agent) IV (infused over a period of not less than 15 minutes) 30 minutes before administration of chemotherapy. The dose may be repeated twice at 2 hour intervals following the initial dose. If vomiting is still not suppressed, the same dose may be repeated 3 more times at 3 hour intervals.

For doses higher than 10 mg, the injection should be diluted in 50 mL of a parenteral solution. Normal saline is the preferred diluent.

If acute dystonic reactions occur, 50 mg of diphenhydramine hydrochloride may be injected IM.

Usual Adult Metoperan 2.6 Dose for Migraine:

Use for treatment of migraine headaches is not an FDA approved indication; however, Metoperan 2.6 has shown efficacy in studies at a dose of 10 to 20 mg IV once (used in combination with analgesics or ergot derivatives).

Usual Pediatric Metoperan 2.6 Dose for Gastroesophageal Reflux Disease:

Metoperan 2.6 is not approved by the FDA for gastroesophageal reflux disease in pediatric patients; however, the following doses have been studied:

Oral, IM, IV:

Infants and Children: 0.4 to 0.8 mg/kg/day in 4 divided doses

Usual Pediatric Metoperan 2.6 Dose for Small Intestine Intubation:

Metoperan 2.6 IV is approved by the FDA for pediatric use to facilitate small bowel intubation by causing gastric emptying where delayed gastric emptying interferes with radiological examination of the stomach and/or small intestine.

If the tube has not passed the pylorus with conventional methods in 10 minutes, a single (undiluted) dose may be administered IV slowly over 1 to 2 minutes:

Less than 6 years: 0.1 mg/kg IV as a single dose

6 to 14 years: 2.5 to 5 mg IV as a single dose

Children greater than 14 years: 10 mg as a single dose

Usual Pediatric Metoperan 2.6 Dose for Nausea/Vomiting -- Chemotherapy Induced:

Metoperan 2.6 is not approved by the FDA for chemotherapy induced nausea and vomiting in pediatric patients; however, the following doses have been studied:

IV:

1 to 2 mg/kg/dose IV every 30 minutes before chemotherapy and every 2 to 4 hours

Usual Pediatric Metoperan 2.6 Dose for Nausea/Vomiting -- Postoperative:

Metoperan 2.6 is not approved by the FDA for postoperative nausea and vomiting in pediatric patients; however, the following doses have been studied:

IV:

Children less than or equal to 14 years: 0.1 to 0.2 mg/kg/dose (maximum dose: 10 mg/dose); repeat every 6 to 8 hours as needed

Children greater than 14 years and Adults: 10 mg; repeat every 6 to 8 hours as needed

Metoperan 2.6 interactions

See also:
What other drugs will affect Metoperan 2.6?

sponsored

Before taking Metoperan 2.6, tell your doctor if you regularly use other medicines that make you sleepy (such as cold or allergy medicine, sedatives, narcotic pain medicine, sleeping pills, muscle relaxers, and medicine for seizures, depression, or anxiety). They can add to sleepiness caused by Metoperan 2.6.

Tell your doctor about all other medications you use, especially:

acetaminophen (Tylenol);

cyclosporine (Gengraf, Neoral, Sandimmune);

digoxin (digitalis, Lanoxin);

glycopyrrolate (Robinul);

levodopa (Larodopa, Atamet, Parcopa, Sinemet);

mepenzolate (Cantil);

tetracycline (Brodspec, Panmycin, Robitet, Sumycin, Tetracap, and others);

atropine (Donnatal, and others), benztropine (Cogentin), dimenhydrinate (Dramamine), methscopolamine (Pamine), or scopolamine (Transderm-Scop);

bladder or urinary medications such as darifenacin (Enablex), tolterodine (Detrol), or solifenacin (Vesicare);

bronchodilators such as ipratroprium (Atrovent) or tiotropium (Spiriva);

irritable bowel medications such as dicyclomine (Bentyl), hyoscyamine (Anaspaz, Cystospaz, Levsin), or propantheline (Pro-Banthine);

an MAO inhibitor such as isocarboxazid (Marplan), phenelzine (Nardil), rasagiline (Azilect), selegiline (Eldepryl, Emsam), or tranylcypromine (Parnate); or

medicines to treat psychiatric disorders, such as chlorpromazine (Thorazine), clozapine (Clozaril, FazaClo), haloperidol (Haldol), olanzapine (Zyprexa, Symbyax), prochlorperazine (Compazine), risperidone (Risperdal), thiothixene (Navane), and others.

Metoperan 2.6 side effects

See also:
What are the possible side effects of Metoperan 2.6?

sponsored

Get emergency medical help if you have any of these signs of an allergic reaction to Metoperan 2.6: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. Stop using Metoperan 2.6 and call your doctor at once if you have any of these serious side effects:

tremors, or restless muscle movements in your eyes, tongue, jaw, or neck;

mask-like appearance of the face;

very stiff (rigid) muscles, high fever, sweating, confusion, fast or uneven heartbeats, tremors, feeling like you might pass out;

depressed mood, thoughts of suicide or hurting yourself;

hallucinations, anxiety, agitation, jittery feeling, trouble staying still;

swelling, fluid retention;

jaundice (yellowing of your skin or eyes); or

seizure (convulsions).

Less serious Metoperan 2.6 side effects may include:

feeling restless, drowsy, tired, or dizzy;

headache, sleep problems (insomnia);

nausea, vomiting, diarrhea;

breast tenderness or swelling;

changes in your menstrual periods; or

urinating more than usual.

Metoperan 2.6 contraindications

See also:
What is the most important information I should know about Metoperan 2.6?

You should not take this medication if you are allergic to Metoperan 2.6, or if you have bleeding or blockage in your stomach or intestines, epilepsy or other seizure disorder, or an adrenal gland tumor (pheochromocytoma).

Active ingredient matches for Metoperan 2.6:

Metoclopramide Hcl


List of Metoperan 2.6 substitutes (brand and generic names)

Sort by popularity
Unit description / dosage (Manufacturer)Price, USD
Briface-OPC 10 mg x 2 Blister x 20 Tablet
DHA Metoclopramide 10 mg x 1000 Tablet
Emeliv 10 mg x 1000's$ 43.00
Gingsuwel 5 mg
Metoran 10 mg/2 mL x 10 tube x 2 mL
Nausin 10 mg x 1000's
R-J Tab/Syrup 10 mg x 1, 000's
R-J Tab/Syrup 5 mg/5 mL x 30 mL
R-J Tab/Syrup 5 mg/5 mL x 1 gal
Syntomide 10 mg x 1's
Vincomid 10 mg/2 mL x 12 tube x 2 ml
Vomaine 5 mg/1 mL x 2 mL x 10's
Weiperan 10 mg x 1000's
YSPPulin 10 mg x 10 Blister x 1o Tablet
YSPPulin 10 mg x 1 Bottle 1000 Tablet

References

  1. PubChem. "metoclopramide". https://pubchem.ncbi.nlm.nih.gov/com... (accessed September 17, 2018).
  2. DrugBank. "metoclopramide". http://www.drugbank.ca/drugs/DB01233 (accessed September 17, 2018).
  3. MeSH. "Antiemetics". https://www.ncbi.nlm.nih.gov/mesh/68... (accessed September 17, 2018).

Reviews

The results of a survey conducted on ndrugs.com for Metoperan 2.6 are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Metoperan 2.6. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.

User reports

Consumer reported useful

No survey data has been collected yet


Consumer reported price estimates

No survey data has been collected yet


Consumer reported time for results

No survey data has been collected yet


Consumer reported age

No survey data has been collected yet


Consumer reviews


There are no reviews yet. Be the first to write one!


Your name: 
Email: 
Spam protection:  < Type 26 here

Information checked by Dr. Sachin Kumar, MD Pharmacology

| Privacy Policy
This site does not supply any medicines. It contains prices for information purposes only.
© 2003 - 2024 ndrugs.com All Rights Reserved